Literature DB >> 18940686

Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings.

Tso-Fu Wang1, Shu-Hui Wen, Rong-Long Chen, Chi-Jui Lu, Ya-Jun Zheng, Shang-Hsien Yang, Sung-Chao Chu, Ruey-Ho Kao, Shu-Huey Chen.   

Abstract

Peripheral blood stem cells (PBSCs) are increasingly used as the source of hematopoietic stem cells, but there are large variations in harvest outcome between individuals mobilized by granulocyte colony-stimulating factor (G-CSF). We examined the effects of donor characteristics and procedure factors on the day 1 CD34+ cell yield in 373 unrelated healthy donors. G-CSF was administered subcutaneously at a planned dose of 8.3 to 11 microg/kg daily for 5 days, followed by harvest started on day 5 of G-CSF treatment. Of the 373 donors, 159 (42.6%) had the radial artery as the inlet access for harvest. Poor day 1 cell yield was defined as <10x10(6) CD34+ cells/L of processed blood for the first apheresis; 62 donors (16.6%) did not attain this threshold. The male donors had significantly higher yields at harvest compared with the female donors. The female donors had higher CD34+ cell yields if the circulation access was through an artery than if is was through a vein. In a multiple regression analysis, donor age, sex, body mass index (BMI), preharvest white blood cell and circulating immature cell counts, access type, and flow rate correlated with day 1 yield. Female sex, older age, venous access, and a higher flow rate were significantly associated with greater risk for a day 1 poor yield of CD34+ cells (odds ratio=3.0074, 1.045, 4.3362, and 1.1131, respectively). A higher BMI may decrease the risk (odds ratio=0.8472). In donors at higher risk for poor CD34+ cell yield, strategies for increasing CD34+ cells must be considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940686     DOI: 10.1016/j.bbmt.2008.09.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  11 in total

1.  Chronic wound repair and healing in older adults: current status and future research.

Authors:  Lisa Gould; Peter Abadir; Harold Brem; Marissa Carter; Teresa Conner-Kerr; Jeff Davidson; Luisa DiPietro; Vincent Falanga; Caroline Fife; Sue Gardner; Elizabeth Grice; John Harmon; William R Hazzard; Kevin P High; Pamela Houghton; Nasreen Jacobson; Robert S Kirsner; Elizabeth J Kovacs; David Margolis; Frances McFarland Horne; May J Reed; Dennis H Sullivan; Stephen Thom; Marjana Tomic-Canic; Jeremy Walston; Jo Anne Whitney; John Williams; Susan Zieman; Kenneth Schmader
Journal:  J Am Geriatr Soc       Date:  2015-03-06       Impact factor: 5.562

2.  The role of donor characteristics and post-granulocyte colony-stimulating factor white blood cell counts in predicting the adverse events and yields of stem cell mobilization.

Authors:  Shu-Huey Chen; Shang-Hsien Yang; Sung-Chao Chu; Yu-Chieh Su; Chu-Yu Chang; Ya-Wen Chiu; Ruey-Ho Kao; Dian-Kun Li; Kuo-Liang Yang; Tso-Fu Wang
Journal:  Int J Hematol       Date:  2011-04-21       Impact factor: 2.490

3.  Chronic wound repair and healing in older adults: current status and future research.

Authors:  Lisa Gould; Peter Abadir; Harold Brem; Marissa Carter; Teresa Conner-Kerr; Jeff Davidson; Luisa DiPietro; Vincent Falanga; Caroline Fife; Sue Gardner; Elizabeth Grice; John Harmon; William R Hazzard; Kevin P High; Pamela Houghton; Nasreen Jacobson; Robert S Kirsner; Elizabeth J Kovacs; David Margolis; Frances McFarland Horne; May J Reed; Dennis H Sullivan; Stephen Thom; Marjana Tomic-Canic; Jeremy Walston; JoAnne Whitney; John Williams; Susan Zieman; Kenneth Schmader
Journal:  Wound Repair Regen       Date:  2015-02-13       Impact factor: 3.617

4.  Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.

Authors:  C Zhang; X-H Chen; X Zhang; L Gao; L Gao; P-Y Kong; X-G Peng; A-H Sun; Y Gong; D-F Zeng; Q-Y Wang
Journal:  Transfus Med       Date:  2010-02-01       Impact factor: 2.019

5.  Correlation between characteristics of unrelated bone marrow donor and cell density of total nucleated cell in bone marrow harvest.

Authors:  Ruey-Ho Kao; Chi-Cheng Li; Cheng-Kuang Shaw; Tso-Fu Wang; Sung-Chao Chu; Shu-Huey Chen; Chao-Yuan Yao; Kuan-Po Huang; Yi-Feng Wu
Journal:  Int J Hematol       Date:  2009-01-08       Impact factor: 2.490

Review 6.  Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update.

Authors:  Yavuz M Bilgin
Journal:  J Blood Med       Date:  2021-06-02

7.  A novel association between relaxin receptor polymorphism and hematopoietic stem cell yield after mobilization.

Authors:  Saeam Shin; Juwon Kim; Soo-Zin Kim-Wanner; Halvard Bönig; Sung Ran Cho; Sinyoung Kim; Jong Rak Choi; Kyung-A Lee
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

8.  Donor-intrinsic variables determine mobilization efficiency: analyses from a cohort of sixty twice-mobilized stem cell donors.

Authors:  Soo-Zin Kim-Wanner; Seo-Youn Lee; Erhard Seifried; Halvard Bonig
Journal:  J Transl Med       Date:  2020-12-18       Impact factor: 5.531

9.  Correlation of Body Mass Index and Proinflammatory Cytokine Levels with Hematopoietic Stem Cell Mobilization.

Authors:  Tso-Fu Wang; Yu-Shan Liou; Hsin-Hou Chang; Shang-Hsien Yang; Chi-Cheng Li; Jen-Hung Wang; Der-Shan Sun
Journal:  J Clin Med       Date:  2022-07-18       Impact factor: 4.964

10.  Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.

Authors:  Nosha Farhadfar; Jack W Hsu; Brent R Logan; Jennifer A Sees; Pintip Chitphakdithai; Michele W Sugrue; Hisham Abdel-Azim; Paolo N Anderlini; Christopher Bredeson; Saurabh Chhabra; Miguel Angel Diaz; Siddhartha Ganguly; Peiman Hematti; Rammurti T Kamble; Kimberly A Kasow; Hillard M Lazarus; Debra Kelly Lynch; Hemant S Murthy; Richard F Olsson; Mona Papari; Donna Przepiorka; Bipin N Savani; Raquel Schears; Sachiko Seo; Melhem M Solh; Thomas Spitzer; Jean A Yared; Michael A Pulsipher; Nirali N Shah; Galen E Switzer; Dennis L Confer; Bronwen E Shaw; John R Wingard
Journal:  Blood Adv       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.